Buerger's Disease
Learn about Buerger's Disease (Thromboangiitis Obliterans) diagnosis, including clinical documentation, medical coding, and healthcare implications. Find information on Buerger's Disease symptoms, treatment, and management. This resource offers guidance for healthcare professionals on accurate coding and documentation for Thromboangiitis Obliterans (Buerger's Disease) in medical records. Understand the importance of proper clinical documentation for Buerger's Disease diagnosis and explore relevant medical coding terminology.
Inflammatory disease of small and medium arteries and veins, typically in the limbs.
Pain, numbness, tingling, skin ulcers, gangrene, especially in fingers and toes.
Outpatient vascular clinics, hospitals for critical limb ischemia or amputation.
ICD-10 Code Families
Complete code families applicable to I73.1
When to use each related code
| Description | When to use |
|---|---|
| Inflammatory blood vessel disease, mainly in legs and feet. | Use for smokers with distal extremity ischemia, claudication, or ulceration. Consider early-onset. |
| Peripheral artery disease reducing blood flow to limbs, usually legs. | Use for atherosclerosis-related lower extremity ischemia, claudication, rest pain, or ulceration. |
| Vasculitis affecting medium and large arteries, typically temporal artery. | Use for patients 50+ with new headaches, jaw pain, visual changes, PMR symptoms. Check ESR/CRP. |
Best-practice checklist
- ✓Buerger's Disease (Thromboangiitis Obliterans) diagnosis documented
- ✓Symptoms: claudication, ischemic pain, ulceration documented
- ✓Physical exam findings: diminished pulses, pallor, cyanosis noted
- ✓Diagnostic tests (e.g., angiography, Doppler ultrasound) results
- ✓ICD-10 code I73.1 for Thromboangiitis Obliterans confirmed
Common pitfalls to avoid
Coding Buerger's Disease requires distinguishing it from similar conditions like peripheral artery disease, impacting accurate reimbursement and quality metrics. Consider documentation improvement.
Insufficient documentation of disease stage (early, advanced) can lead to undercoding or overcoding, affecting healthcare analytics and compliance audits for I70 codes.
Associated conditions like tobacco use (Z72.0) must be accurately documented and coded alongside Buerger's Disease to reflect overall patient health and justify treatment.
Best-practice tips
- 01Smoking cessation: vital for Buerger's management. ICD-10 I73.1
- 02Wound care, prevent infection: critical for limb preservation. ICD-10 L97.909
- 03Pain management: analgesics, spinal cord stimulation. ICD-10 G54.9
- 04Avoid cold exposure: protect extremities, maintain warmth. ICD-10 T69.8XXA
- 05Supervised exercise program: improve circulation, function. ICD-10 Z79.89
Step-by-step checklist
- 1
History of smoking (current or recent)
- 2
Distal extremity ischemia symptoms (pain, claudication)
- 3
Absence of diabetes, autoimmune disease, hyperlipidemia
- 4
Positive Allen's test or similar vascular assessment
- 5
Age <45, typically male
Ready-to-paste narrative
Patient presents with complaints consistent with Buerger's disease, also known as thromboangiitis obliterans. Symptoms include distal extremity pain, claudication in the feet and hands, ischemic rest pain, and ulcerations. Physical exam reveals diminished or absent pulses in the affected extremities, coolness to the touch, and pallor or cyanosis. The patient is a current smoker with a significant smoking history. Differential diagnoses considered include peripheral artery disease (PAD), Raynaud's phenomenon, and diabetic microvascular complications. Given the patient's age, smoking history, and clinical presentation, Buerger's disease is the most likely diagnosis. Initial treatment plan includes smoking cessation counseling and education on the importance of complete abstinence from tobacco products. Pharmacological interventions may be considered for pain management and improvement of blood flow. Referral to vascular surgery is warranted for further evaluation and potential revascularization procedures if indicated. Patient education regarding foot care and prevention of further complications will be provided. Follow-up appointment scheduled to monitor disease progression and treatment efficacy. ICD-10 code I73.1 for thromboangiitis obliterans will be used for billing and coding purposes.
Common questions and answers
What are the key differentiating factors in diagnosing Buerger's Disease (Thromboangiitis Obliterans) vs. other peripheral vascular diseases like atherosclerosis?+
Differentiating Buerger's Disease from other peripheral vascular diseases like atherosclerosis requires careful consideration of several factors. Buerger's typically affects young male smokers and presents with distal extremity ischemia, often in the hands and feet. Atherosclerosis, on the other hand, tends to affect older individuals with risk factors like hyperlipidemia and diabetes, and can involve larger vessels. While both can cause claudication, Buerger's often presents with rest pain and ischemic ulcerations earlier in the disease course. Histopathology reveals segmental inflammatory thrombosis in Buerger's, unlike the atheromatous plaques seen in atherosclerosis. A strong smoking history in a young patient with distal extremity ischemia should raise suspicion for Buerger's. Explore how a detailed patient history and physical exam, combined with angiographic findings, can help distinguish Buerger's from similar conditions.
How does smoking cessation impact the progression and management of Buerger's Disease (Thromboangiitis Obliterans) in clinical practice?+
Smoking cessation is the cornerstone of Buerger's Disease (Thromboangiitis Obliterans) management. Continued smoking invariably leads to disease progression and increased risk of amputation. Conversely, complete abstinence can halt disease progression and significantly improve symptoms like claudication and rest pain. While existing damage may not be reversible, quitting smoking can prevent further vascular compromise and reduce the risk of future amputations. Clinicians should strongly advise all patients diagnosed with Buerger's to stop smoking immediately and offer appropriate support, including counseling and pharmacological interventions. Consider implementing a structured smoking cessation program as part of the overall management strategy. Learn more about the evidence-based resources available to assist patients with smoking cessation.
Beyond smoking cessation, what other treatment strategies are recommended for managing severe cases of Buerger's Disease (Thromboangiitis Obliterans) and preventing amputation?+
While smoking cessation is paramount, severe cases of Buerger's Disease (Thromboangiitis Obliterans) may require additional interventions to manage symptoms and prevent amputation. Pharmacological options, such as prostanoids and calcium channel blockers, can help improve blood flow and reduce pain. Endovascular procedures, like angioplasty, may be considered in some cases to revascularize affected vessels. However, surgical bypass is often challenging due to the distal nature of the disease. Pain management is crucial and may involve multimodal approaches, including analgesics and regional anesthesia. Wound care is essential for patients with ulcerations to prevent infection and promote healing. Regular follow-up is necessary to monitor disease progression and adjust treatment as needed. Consider implementing a multidisciplinary approach involving vascular specialists, pain management specialists, and wound care nurses to optimize outcomes and improve patient quality of life.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.